Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Mar 31, 2017 | $6.15B |
| FY2018, ended Mar 31, 2018 | $11.2B |
| FY2019, ended Mar 31, 2019 | $10.6B |
| FY2020, ended Mar 31, 2020 | $13.5B |
| FY2021, ended Mar 31, 2021 | $20.4B |
| FY2022, ended Mar 31, 2022 | $17.8B |
| FY2023, ended Mar 31, 2023 | $20.2B |
| FY2024, ended Mar 31, 2024 | $25.4B |
| FY2025, ended Mar 31, 2025 | $36.8B |
| FY2026, ended Mar 31, 2026 | $36.7B |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | $46.7B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Mar 31, 2017 | $1.78B |
| FY2018, ended Mar 31, 2018 | $1.79B |
| FY2019, ended Mar 31, 2019 | $2.67B |
| FY2020, ended Mar 31, 2020 | $3.09B |
| FY2021, ended Mar 31, 2021 | $3.37B |
| FY2022, ended Mar 31, 2022 | $3.50B |
| FY2023, ended Mar 31, 2023 | $5.35B |
| FY2024, ended Mar 31, 2024 | $5.35B |
| FY2025, ended Mar 31, 2025 | $5.63B |
| FY2026, ended Mar 31, 2026 | $6.66B |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | $6.69B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Mar 31, 2017 | $67.3M | $387M |
| FY2018, ended Mar 31, 2018 | $174M | $432M |
| FY2019, ended Mar 31, 2019 | $334M | $777M |
| FY2020, ended Mar 31, 2020 | $404M | $632M |
| FY2021, ended Mar 31, 2021 | $589M | $843M |
| FY2022, ended Mar 31, 2022 | $418M | $99.4M |
| FY2023, ended Mar 31, 2023 | −$1.12B | −$203M |
| FY2024, ended Mar 31, 2024 | −$3.74B | −$158M |
| FY2025, ended Mar 31, 2025 | −$4.48B | −$215M |
| FY2026, ended Mar 31, 2026 | −$298M | $462M |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | −$320M | $338M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Mar 31, 2017 | $943M |
| FY2018, ended Mar 31, 2018 | $809M |
| FY2019, ended Mar 31, 2019 | $827M |
| FY2020, ended Mar 31, 2020 | $1.36B |
| FY2021, ended Mar 31, 2021 | $1.42B |
| FY2022, ended Mar 31, 2022 | $1.73B |
| FY2023, ended Mar 31, 2023 | $827M |
| FY2024, ended Mar 31, 2024 | $754M |
| FY2025, ended Mar 31, 2025 | $1.46B |
| FY2026, ended Mar 31, 2026 | $1.55B |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | $1.36B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Mar 31, 2017 | $268M |
| FY2018, ended Mar 31, 2018 | $8.16M |
| FY2019, ended Mar 31, 2019 | $0 |
| FY2020, ended Mar 31, 2020 | — |
| FY2021, ended Mar 31, 2021 | — |
| FY2022, ended Mar 31, 2022 | $0 |
| FY2023, ended Mar 31, 2023 | $3.08B |
| FY2024, ended Mar 31, 2024 | $3.08B |
| FY2025, ended Mar 31, 2025 | $3.66B |
| FY2026, ended Mar 31, 2026 | $2.52B |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | $2.52B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 80.1% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Mar 31, 2017 | 104M |
| FY2018, ended Mar 31, 2018 | 114M |
| FY2019, ended Mar 31, 2019 | 113M |
| FY2020, ended Mar 31, 2020 | 114M |
| FY2021, ended Mar 31, 2021 | 116M |
| FY2022, ended Mar 31, 2022 | 116M |
| FY2023, ended Mar 31, 2023 | 169M |
| FY2024, ended Mar 31, 2024 | 171M |
| FY2025, ended Mar 31, 2025 | 177M |
| FY2026, ended Mar 31, 2026 | 186M |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | 187M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2017, ended Mar 31, 2017 | $0 | $81.9M | — | $57.3M |
| FY2018, ended Mar 31, 2018 | $155M | $116M | $0 | — |
| FY2019, ended Mar 31, 2019 | $362M | $248M | $0 | — |
| FY2020, ended Mar 31, 2020 | $0 | $258M | $10.5M | — |
| FY2021, ended Mar 31, 2021 | $0 | $111M | $14.2M | $97.6M |
| FY2022, ended Mar 31, 2022 | $200M | $183M | $19.7M | $94.1M |
| FY2023, ended Mar 31, 2023 | $0 | $318M | $65.4M | — |
| FY2024, ended Mar 31, 2024 | $0 | $336M | $39.4M | — |
| FY2025, ended Mar 31, 2025 | — | $324M | $77.3M | $449M |
| FY2026, ended Mar 31, 2026 | — | $305M | $1.25B | — |
| Trailing 12 months to Jun 30, 2026 (through Q1 FY2027) | — | $351M | $59.7M | — |
Valuation
At current price- Market Cap
- $37.6B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.6×
- Price / Book
- 10.4×
- EV / EBITDA
- 1108×
Growth
Trailing 12 months- Revenue (TTM)
- $6.69B
- Revenue Growth YoY
- 15.3%
- Revenue CAGR 3Y
- 7.6%
- Revenue CAGR 5Y
- 14.6%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 56.0%
- Operating Margin
- −2.4%
- Net Margin
- −4.8%
- FCF Margin
- 5.0%
- Return on Equity
- −9.0%
Earnings
Trailing 12 months- Net Income
- −$320M
- EPS (diluted)
- −$1.73
- EBITDA
- $35.0M
- Operating Income
- −$161M
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.36B
- Total Debt
- $2.52B
- Net Debt
- $1.15B
- Total Assets
- $9.06B
- Total Liabilities
- $5.46B
- Shareholders' Equity
- $3.61B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $500M
- Capital Expenditure
- $163M
- Free Cash Flow
- $338M
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.98
Every ratio is calculated from the company’s reported figures.